
A new study titled, “Prevalence of Diabetic Retinopathy in the US in 2021,” finds that almost 10 million people in the United States with diabetes have diabetic retinopathy.

A new study titled, “Prevalence of Diabetic Retinopathy in the US in 2021,” finds that almost 10 million people in the United States with diabetes have diabetic retinopathy.

Since 2014 when a sheet of retinal pigment epithelial cells derived from iPS cells was transplanted into patients with age-related macular degeneration, clinical trials have been conducted with various cell types derived from iPS cells.

The open-access tool is the official registry partner of the European Glaucoma Society.

In a study of 1.7 million older Americans by a team of researchers from the University of Toronto, those living in counties with an average temperature of 60°F or above had an increased chance of suffering serious vision impairment than those in cooler counties.

The fellowship is a one-year program that will provide comprehensive training to residency graduates in the latest advancements in ophthalmology, including diagnostic and therapeutic techniques, surgical procedures and clinical research.

A study found the approach identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam.

The fellowship is a one-year program that will provide comprehensive training to residency graduates in the latest advancements in ophthalmology, including diagnostic and therapeutic techniques, surgical procedures, and clinical research.

Surgeon discusses latest trends for treating cornea.

Trainees learn to recognize key pathologies seen in fundus examinations, OCT images

Intergalactic's non-viral gene therapy platform is designed to overcome limitations of standard adeno-associated virus (AAV) gene therapy technologies.

Clinical trial investigator Victor H. Gonzalez, MD, presented data at the 83rd Scientific Sessions of the American Diabetes Association in San Diego, California.

The company has entered a definitive agreement with Novartis to acquire Xiidra (liftegrast ophthalmic solution 5%), representing a significant opportunity for growth in prescription dry eye.

Orbis International physician spotlights the latest trends for cataract surgery training.

Gonzalez shared that the ZETA-1 trial results demonstrate the potential of APX3330 to slow disease progression as well as highlight its favorable safety profile in the diabetic patient population.

Procedures in the pipeline hold greater appeal for cataract and refractive surgeons, patients.

Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss IAT for CRAO within 16 hours.

Preliminary results indicate significant improvement for patients and ‘very good safety profile’

The two-hour event will share details on the company’s clinical programs for retina diseases through formal presentations and a live Q&A session.

Special Superior Court Judge Mark A. Davis ruled that Michael Woodcock, MD’s failure to answer court filings did not mean he admitted his guilt in the allegations made by Cumberland County Hospital System.

According to Horizon Therapeutics, the analysis shows subclinical spinal cord lesions were associated with future NMOSD attacks. The analysis was being presented at the 9th Congress of the European Academy of Neurology in Budapest.

Results reported in JAMA Ophthalmology show that about 20% of those with diabetic retinopathy have a case that could threaten their vision.

The investigators have developed a clinically robust HH-SECTR system, which has a modular aluminum probe design and micrometer-scale mechanical stability.


The investigators evaluated corrective surgery procedures to determine their effect on ocular outcomes.

According to the companies, the divested assets will include Xiidra and SAF312, a potential therapy for chronic ocular surface pain. The deal is expected to close later this year.

The severity and duration of gene therapy–associated uveitis correlated with increasing vector dose.

The study demonstrated a meaningful increase in the long chain and very long chain polyunsaturated fatty acids whose deficit is associated with dry AMD.

In his role as president elect, SriniVas Sadda, MD, will continue to serve on the board as well as begin planning for his term as president, which will kick off next May at the conclusion of ARVO’s 2024 Annual Meeting in Seattle, Washington.

As part of its effort, the company is kicking off a new social media campaign in July designed to increase the understanding of dry eye disease.